CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be participating in the following conferences in February 2013:
- 2013 Leerink Swann Healthcare Conference, New York, February 13, 2013, at 9:00 a.m. ET
- Citi 2013 Global Healthcare Conference, New York, February 25, 2013, at 9:35 a.m. and 2:15 p.m. ET (panel discussions)
- 2013 RBC Capital Markets Global Healthcare Conference, New York, February 27, 2013, at 10:00 a.m. ET
A live webcast of each of Infinity's presentations will be accessible on the “investors/media” section of the company's website, www.infi.com, and will be available for 30 days following each event.
About Infinity Pharmaceuticals, Inc.
Infinity is an
innovative drug discovery and development company seeking to discover,
develop and deliver to patients best-in-class medicines for diseases
with significant unmet need. Infinity combines proven scientific
expertise with a passion for developing novel small molecule drugs that
target emerging disease pathways. Infinity’s programs focused on the
inhibition of phosphoinositide-3-kinase and heat shock protein 90 are
evidence of its innovative approach to drug discovery and development.
For more information on Infinity, please refer to the company’s website
at www.infi.com.